A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis

Cancer Research

Volumn 73, Issue 21, 2013, Pages 6401-6412

  Sheltzer, Jason M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; ANIMAL CELL; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CELL PROLIFERATION; CELL STRESS; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CITRIC ACID CYCLE; GLYCOLYSIS; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; SURVIVAL PREDICTION; SURVIVAL RATE; TRANSCRIPTOMICS; UPREGULATION;

ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CHROMOSOMAL INSTABILITY; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887145591     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-0749     Document Type: Article

References (60)

1. Holland AJ, Cleveland DW. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 2009;10: 478-87.
2. Sheltzer JM, Blank HM, Pfau SJ, Tange Y, George BM, Humpton TJ, et al. Aneuploidy drives genomic instability in yeast. Science 2011;333: 1026-30.
3. Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 2010;188: 369-81.
4. Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A 1998;95: 13692-7.
5. Zhu J, Pavelka N, Bradford WD, Rancati G, Li R. Karyotypic determinants of chromosome instability in aneuploid budding yeast. PLoS Genet 2012;8:e1002719.
6. Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol 2006;18: 658-67.
7. McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep 2012;13: 528-38.
8. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 2007;317: 916-24.
9. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, Housman DE, et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 2008;322: 703-9.
10. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol 2008;180: 665-72.
11. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010;468: 321-5.
12. Tang Y-C, Williams BR, Siegel JJ, Amon A. Identification of aneuploidy- selective antiproliferation compounds. Cell 2011;144: 499-512.
13. Nizetic D, Groet J. Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nat Rev Cancer 2012;12: 721-32.
14. Sotillo R, Hernando E, Díaz-Rodríguez E, Teruya-Feldstein J, Cordon-Cardo C, Lowe SW, et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007;11: 9-23.
15. Sotillo R, Schvartzman J-M, Socci ND, Benezra R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 2010;464: 436-40.
16. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, et al. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci U S A 2010;107: 14188-93.
17. Weaver BAA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007;11: 25-36.
18. Baker DJ, Jin F, Jeganathan KB, van Deursen JM. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 2009;16: 475-86.
19. Remeseiro S, Cuadrado A, Carretero M, Martínez P, Drosopoulos WC, Cañamero M, et al. Cohesin-SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres. EMBO J 2012;31: 2076-89.
20. Birkbak NJ, Eklund AC, Li Q, McClelland SE, Endesfelder D, Tan P, et al. Paradoxical relationship between chromosomal instability and survival outcome in cancer. Cancer Res 2011;71: 3447-52.
21. Zasadil LM, Britigan EMC, Weaver BA. 2n or not 2n: aneuploidy, polyploidy, and chromosomal instability in primary and tumor cells. Semin Cell Dev Biol 2013;24: 370-9.
22. Sheltzer JM, Torres EM, Dunham MJ, Amon A. Transcriptional consequences of aneuploidy. Proc Natl Acad Sci U S A 2012;109: 12644-9.
23. Ried T, Hu Y, Difilippantonio MJ, Ghadimi BM, Grade M, Camps J. The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. Biochim Biophys Acta 2012;1819: 784-93.
24. Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, Reinhold WC, et al. CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 2009;10: 277.
25. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, Valmeekam V, et al. NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 2003;31: 82-6.
26. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res 2003;63: 8634-47.
27. NCI60 Discovery Services [Internet]. Available from: http://dtp.nci.nih. gov/docs/misc/common-files/cell-list.html.
28. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, et al.Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012;336: 1040-4.
29. Stingele S, Stoehr G, Peplowska K, Cox J, Mann M, Storchova Z. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol 2012; 8: 608.
30. Reimand J, Arak T, Vilo J. g:Profiler - a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 2011; 39:W307-15.
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102: 15545-50.
32. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011;27: 1739-40.
33. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0 - a comprehensive server for metabolomic data analysis. Nucl Acids Res 2012;40:W127-33.
34. De Hoon MJL, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics 2004;20: 1453-4.
35. Saldanha AJ. Java Treeview - extensible visualization of microarray data. Bioinformatics 2004;20: 3246-8.
36. Roschke AV, Glebov OK, Lababidi S, Gehlhaus KS, Weinstein JN, Kirsch IR. Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance. Neoplasia 2008;10: 1222-30.
37. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. BioTechniques 2003;34: 374-8.
38. Karlsson E, Delle U, Danielsson A, Olsson B, Abel F, Karlsson P, et al. Gene expression variation to predict 10-year survival in lymph-nodenegative breast cancer. BMC Cancer 2008;8: 254.
39. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 2004;36: 744-9.
40. Li M, Fang X, Wei Z, York JP, Zhang P. Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. J Cell Biol 2009;185: 983-94.
41. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genet 2006; 38: 1043-8.
42. Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, et al. Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A 2009;106: 8671-6.
43. Salvatore G, Nappi TC, Salerno P, Jiang Y, Garbi C, Ugolini C, et al. A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Res 2007;67: 10148-58.
44. Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P, et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du My-elome. J Clin Oncol 2008;26: 4798-805.
45. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396: 643-9.
46. Venet D, Dumont JE, Detours V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 2011;7:e1002240.
47. Dai H, van't Veer L, Lamb J, He YD, Mao M, Fine BM, et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res 2005;65: 4059-66.
48. Mosley JD, Keri RA. Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics 2008;1: 11.
49. Sheltzer JM, Amon A. The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet 2011;27: 446-53.
50. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88: 323-31.
51. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JKV, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50: 7717-22.
52. Lassam NJ, From L, Kahn HJ. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 1993;53: 2235-8.
53. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993;53: 4477-80.
54. Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 2011;71: 1858-70.
55. Bakhoum SF, Danilova OV, Kaur P, Levy NB, Compton DA. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2011;17: 7704-11.
56. Raspe E, Decraene C, Berx G. Gene expression profiling to dissect the complexity of cancer biology: pitfalls and promise. Semin Cancer Biol 2012;22: 250-60.
57. Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005;92: 1188-92.
58. Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan- Dylon S, Huergo SPM, et al. Targeting galectin-1 overcomes breast cancer associated immunosuppression and prevents metastatic disease. Cancer Res 2013;73: 1107-17.
59. Banh A, Zhang J, Cao H, Bouley DM, Kwok S, Kong C, et al. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis. Cancer Res 2011;71: 4423-31.
60. Ruoslahti E. Fibronectin and its integrin receptors in cancer. In: Woude GFV, Klein G, editors. Advances in cancer research [Internet]. Academic Press; 1999 [cited 2012 Dec 21], p. 1-20. Available from: http://www. elsevier.com/books/advances-in-cancer-research/vande-woude/978-0-12-006679-7#.